AAN 2011 guidelines
|
Recommendations for use |
Treatment |
|
Level A – should be offered to patients who desire treatment for limb tremor in ET, depending on concurrent medical conditions and potential side effects |
Primidone Propranolol Propranolol LA |
|
Level B – probably effective and should be considered to reduce limb tremor in ET |
Alprazolam Atenolol Gabapentin
(monotherapy) Sotalol Topiramate |
|
Level B – probably effective and should be considered to reduce head tremor in ET |
Propranolol |
|
Level C – possibly effective and may be considered to reduce limb tremor associated with ET |
Botulinum toxin A injection of forearm muscles Clonazepam Nadolol Nimodipine |
|
Recommendations against use |
Treatment |
|
Level B – probably do not reduce limb tremor in ET and should not be considered for treatment of limb tremor in ET |
3,4-diaminopyridine** Acetazolamide Isoniazid Levetiracetam** Pindolol Trazodone |
|
Level C – possibly do not reduce limb tremor in ET and may not be considered for treatment of limb tremor in ET |
Flunarizine** Methazolamide Mirtazapine Nifedipine Verapamil |
|
Level U – Insufficient evidence to support or refute efficacy in treating ET |
Amantadine Clonidine Clozapine** Gabapentin (adjunct therapy) Glutethimide L-tryptophan/pyridoxine Metoprolol Nicardipine Olanzapine** Oxcarbazepine Phenobarbital Pregabalin** Quetiapine Sodium oxybate (in ethanol-sensitive ET) Theophylline Tiagabine Zonisamide** |
**The conclusion and recommendation are new or different from those in the previous guideline.
|
Recommendations
for use |
Treatment |
|
Level C – effectively treats contralateral limb tremor in ET that is refractory to medication management |
Unilateral thalamotomy
DBS of the VIM of the thalamus23–27 |
|
Level U – insufficient evidence to support or refute efficacy in treating ET |
Superiority of DBS or thalamotomy for the treatment of ET Relative advantages and disadvantages of unilateral vs bilateral DBS in the treatment of limb tremor Direct subthalamic stimulation and/or zona incerta/prelemniscal stimulation Gamma knife thalamotomy |
DBS = deep brain stimulation, VIM = ventral intermediate nucleus.
• 60-320mg/day (average dose in trial 185mg/day)
• Reduced tremor by 50% clinically
• Long acting preparation appeared to have similar efficacy.
• Up to 750mg/day
• Average dose 480mg/day
• Slow titration up from 25mg daily
• Significant SE - sedation, drowsiness, fatigue, depression, nausea, vomiting, ataxia etc.